2nd Edition of Cell & Gene Therapy World Conference(CGTWC) 2026

Scientific Sessions

Analytics, Potency Assays, and Rapid Release Strategies

The use of analytics and potency assays is now integral to the characterization of complex biological products, in addition to being essential for regulatory submissions and the maintenance of batch-to-batch consistency. The commitment to the consistency, safety, and efficacy of sophisticated therapies necessitates the introduction of a new generation of analytical tools and quality supports. The Cell & Gene Therapy forum will give opinions of the experts in analytical science, regulatory science, and manufacturing to present on current advancements in the standardization of assays, automation, and data-driven release. This session will assess novel approaches that improve knowledge of processes, qualify products in real-time, and strengthen the scientific basis for the worldwide accelerated, compliant delivery of therapies.

Related Sessions

CRISPR Cas9 and Beyond: Emerging Genome Editing Platforms
Precision Genome Editing: From Target Discovery to Clinical Application
Engineering the Immune System: Gene and Cell Based Modulation
Non Viral Gene Delivery Strategies: Safety, Scalability, and Translation
Stem Cell Derived Therapeutics: iPSCs, Organoids and Tissue Engineering
Allogeneic vs Autologous Cell Therapies: Manufacturing, Efficacy, and Access
Manufacturing for Personalized Medicine: Customised Cell Products at Scale
Analytics, Potency Assays, and Rapid Release Strategies
CGTs for Monogenic Disorders: Delivering the Cure
Gene and Cell Therapies in Oncology: CAR T, NK, TCR, Oncolytic Approaches
Neurological and Neurodegenerative Disease Applications of CGTs
Market Access, Health Economics, and Reimbursement in CGT
Global Access and Equity: Bridging the CGT Innovation Gap
The Future Landscape of Cell and Gene Therapies: 2030 and Beyond
Cell and Gene Therapy Clinical Development
Cell and Gene Therapy Pipeline Analysis